Target intelligence / Profile preview

ATP synthase subunit c of Mycobacterium tuberculosis (AtpE)

Target
AtpE
Molecular classification
Enzyme, Membrane protein, Ion transporter
01

Overview

ATP synthase subunit c of Mycobacterium tuberculosis (AtpE) is an integral membrane component of the F0 sector of the bacterial ATP synthase complex, forming part of the rotary c-ring that translocates protons across the membrane to drive the synthesis of ATP. It is essential for the energy metabolism of M. tuberculosis, enabling survival and persistence of the bacterium under both replicating and dormant conditions. Its unique structural features, which differ sufficiently from the human mitochondrial ATP synthase, allow selective targeting by the anti-tubercular drug bedaquiline. The high-affinity and specificity of drugs like bedaquiline for the mycobacterial c-ring make ATP synthase subunit c a central validated drug target in tuberculosis therapy, but the risk of drug resistance due to mutations must be considered[4][5][7].

Other names
AtpEc subunit of F1Fo-ATP synthaseF0 c subunitFo c subunit
02

Mechanism of action

Inhibition of proton translocation by binding to the c-ring, blocking rotation and thereby ATP production Destabilization of ATP synthase function, leading to energy collapse in the bacterium

03

Biological functions

ATP synthesisProton translocationOxidative phosphorylation
04

Disease associations

Infection
05

Safety considerations

Off-target effects possible with ATP synthase inhibitors, due to conservation of the enzyme in mitochondria of host cells, although bedaquiline shows high specificity for mycobacterial subunit cEmergence of drug resistance due to mutations in atpE gene (coding for subunit c)
06

Interacting drugs

Bedaquiline (BDQ, Sirturo)

2 more in the full profile.

07

Biomarkers

None established for patient selection or monitoring efficacy; target is used as a biomolecular marker in drug resistance surveillance when mutations confer bedaquiline resistance

Beyond the preview

Go deeper on ATP synthase subunit c of Mycobacterium tuberculosis (AtpE).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ATP synthase subunit c of Mycobacterium tuberculosis (AtpE).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call